NL-OMON50135
Not yet recruiting
Not Applicable
Cardiomyopathy and heart failure risk after treatment for Hodgkin lymphoma or aggressive B cell non-Hodgkin lymphoma - CRYSTAL case-control
ederlands Kanker Instituut0 sites800 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- cardiomyopathy
- Sponsor
- ederlands Kanker Instituut
- Enrollment
- 800
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All lymphoma survivors who meet the inclusion criteria of the P11CHT study or
- •the CRYSTAL cohort study are eligible for the CRYSTAL case\-control study. The
- •most important inclusion criteria for the P11CHT and CRYSTAL cohort study are:
- •\* Diagnosis of Hodgkin's lymphoma (P11CHT) or aggressive B\-cell non\-Hodgkin's
- •lymphoma (CRYSTAL cohort)
- •\* Treatment for the lymphoma between 1965 and 2005 (P11CHT) or between 1989 and
- •2012 (CRYSTAL cohort)
- •\* Age at diagnosis \<51 years (P11CHT) or \<61 years (CRYSTAL cohort)
- •\* Still alive at least 5 years after primary lymphoma treatment
Exclusion Criteria
- •\* A history of (symptomatic) myocardial infarction, valvular heart disease,
- •cardiomyopathy or heart failure before lymphoma diagnosis
- •\* Chemotherapy or immunotherapy for a primary malignancy before lymphoma
- •\* Radiotherapy to the trunk before lymphoma diagnosis
- •\* Myocardial infarction or \*CTCAE grade 2 valvular heart disease prior to
- •diagnosis of cardiomyopathy or heart failure
- •\* Insufficient understanding of the Dutch language (for survivors receiving the
- •questionnaire)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Investigation of the effects of heart failure with preserved ejection fraction (HFpEF) on cerebral small vessel diseaseHeart failure with preserved ejection fraction (HFpEF)DRKS00031583niversitätsklinikum Magdeburg102
Recruiting
Not Applicable
Heart Failure and Related Risk Factors after PreeclampsiaHeart failure and Preeclampsia100192801001027310057166NL-OMON54718Medisch Universitair Ziekenhuis Maastricht2,580
Recruiting
Not Applicable
Impact of cardiac and autonomic nervous system alterations in cirrhosis patients.CTRI/2021/12/038676Post Graduate Institute of Medical Education and Research
Recruiting
Not Applicable
Hypertrophic cardiomyopathy: Clinical impact of a prolonged mHealth-based arrhythmia monitoring by single-channel ECGI42.1Obstructive hypertrophic cardiomyopathyDRKS00032144niversitätsklinik für Kardiologie und Internistische Intensivmedizin34
Completed
Not Applicable
Cardiac dysfunction and undiagnosed heart failure in women as a long term effect of the treatment of breast cancer in an unselected primary care settingcardiac dysfunctionheart failure1008220610018865NL-OMON39592niversitair Medisch Centrum Groningen700